Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18-75 yr~* Willingness to provide written informed consent~* Ability to understand the study procedures~Exclusion Criteria:~* Life expectancy \< 3 months~* Claustrophobia~* Allergy to iodinated contrast~* Treatment incompliance~* Pregnancy~* Highly HLA-sensitized patients~* Severe dyslipidemia or proteinuria~* Severe leucopenia or thrombocytopenia~* GFR \< 30 ml/min

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- everolimus-based immunosuppression (Type: EXPERIMENTAL): immunosuppression with everolimus, prednisone and mycophenolate
- standard immunosuppression (Type: ACTIVE_COMPARATOR): immunosuppression with tacrolimus, prednisone and mycophenolate

Based on this trial design, predict the completion outcome and termination type (if applicable).